Assessing the severity of migraine: Development of the MIGSEV scale. Editorial comment

Headache

Volumn 43, Issue 6, 2003, Pages 636-637

  Lipton, Richard B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CLINICAL PRACTICE; CLINICAL RESEARCH; DISABILITY; DISEASE SEVERITY; HEADACHE; HUMAN; MIGRAINE; NOTE; PAIN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; CLASSIFICATION; HOSPITALIZATION;

HUMANS; MIGRAINE DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 0141765754     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03125.x     Document Type: Note

References (14)

1. Stewart WF, Lipton RB, Simon D, Liberman J, Von Korff M. Validity of an illness severity measure for headache in a population sample of migraine sufferers. Pain. 1999;79:291-301.
2. Dahlof CG, Solomon GD. The burden of migraine to the individual sufferer: a review. Eur J Neurol. 1998;5:525-533.
3. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999;53:988-994.
4. Stewart WF, Lipton RB, Kolodner KB, et al. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:41-52.
5. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford Hospital Headache Disability Inventory (HDI). Neurology. 1994;44:837-842.
6. McKenna SP, Doward LC, Davey KM. The development and psychometric properties of the MSQOL - a migraine-specific quality-of-life instrument. Clin Drug Invest. 1998;15:413-423.
7. Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ version 2.1). Headache. 2000;40:204-215.
8. Patrick DL, Hurst BC, Hughes J. Further development and testing of the migraine -specific quality of life (MSQOL) measure. Headache. 2000;40:550-560.
9. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache. 1995;35:330-337.
10. Lipton RB. Disability assessment as a basis for stratified care. Cephalalgia. 1998;18:40-46.
11. Lipton RB, Silberstein SD. The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology. 2001;56(suppl 1):S35-S42.
12. Lipton RB, Stewart AF, Stone FM, Lainez MJ, Sawyer JP. Stratified care vs step-care strategies for migraine - the disability in strategies of care (DISC) study: a randomized trial. JAMA. 2000;284:2599-2605.
13. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al, for the Canadian Headache Society. Guidelines for the diagnosis and management of migraine in clinical practice. CMAJ. 1997;156:1273-1287.
14. Cady RK, Sheftell F, Lipton RB, et al. Effects of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther. 2000;22:1035-1048.